Long-term Safety and Efficacy of a Modified Suprachoroidal Silicone Tube (SST) Shunt
Recruiting
Observational Study
Glaucoma
Open Angle Glaucoma (OAG)
POAG
Ocular Hypertension
Exfoliation Syndrome
Choroidal Effusions
No Placebo Group
Every participant receives an active treatment — no one gets a placebo.
No Study Drug
Researchers observe your health over time — no experimental treatment is given.
At a Glance
- Age
- 40 – 90
- Sex
- Any
- Study type
- Observational
- Participants needed
- 66 (estimated)
- Sponsor
- Davinci LTD · Other
Think this trial could be right for you?
Answer a few quick questions to see if you may meet the eligibility requirements.
Check Your Eligibility
About This Trial
The goal of this observational study is to evaluate the long-term safety and efficacy of a modified suprachoroidal silicone tube (SST) shunt in treating patients with primary open-angle glaucoma (POAG) and pseudo-exfoliative glaucoma (PXG).
The main questions it aims to answer are:
Does the SST shunt maintain intraocular pressure (IOP) reduction over an extended follow-up period? What is the eff…
Trial Locations
Loading…
Loading trial locations…
Eligibility Criteria
Inclusion Criteria:
* Previously were treated with Suprachoroidal silicone tube shunt
* Willing and able to participate in this cross sectional observational follow up
* Participant capable of giving informed consent
Exclusion Criteria:
* Condition that could impact the ability of the participant…
Contacts